Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Nu Skin ( (NUS) ) just unveiled an update.
On May 6, 2026, Nu Skin announced that Steven K. Hatchett would resign as Executive Vice President and Chief Product Officer, effective May 8, 2026, citing family health circumstances. The company noted that Hatchett will remain with Nu Skin as a strategic product advisor, receiving an annual salary of $147,478, signaling continuity in product strategy despite the leadership change.
The transition suggests Nu Skin is aiming to retain Hatchett’s expertise while managing the impact of his departure from the C-suite. By keeping him in an advisory role, the company appears to be safeguarding institutional knowledge and product development continuity, which may reassure investors and other stakeholders about the stability of its product leadership.
Spark’s Take on NUS Stock
According to Spark, TipRanks’ AI Analyst, NUS is a Neutral.
The score is held back primarily by multi-year revenue decline and weak technical setup (price below key moving averages with negative momentum). Partially offsetting this are a de-risked balance sheet and improved profitability versus 2024, plus maintained guidance and expected sequential improvement; however, the high P/E and ongoing margin pressure limit upside conviction.
To see Spark’s full report on NUS stock, click here.
More about Nu Skin
Nu Skin is a personal care and wellness company that develops and markets beauty, skincare, and nutritional products, with a focus on product innovation and a global consumer base.
Average Trading Volume: 527,683
Technical Sentiment Signal: Strong Sell
Current Market Cap: $345.2M
For a thorough assessment of NUS stock, go to TipRanks’ Stock Analysis page.